Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$269M |
| 2 |
Amazon
AMZN
|
+$242M |
| 3 |
Apple
AAPL
|
+$215M |
| 4 |
Amgen
AMGN
|
+$212M |
| 5 |
Citizens Financial Group
CFG
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$210M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$195M |
| 3 |
iShares GSCI Commodity Dynamic Roll Strategy ETF
COMT
|
+$154M |
| 4 |
MXIM
Maxim Integrated Products
MXIM
|
+$127M |
| 5 |
WORK
Slack Technologies, Inc.
WORK
|
+$115M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.58% |
| 2 | Financials | 13.47% |
| 3 | Healthcare | 12.09% |
| 4 | Consumer Discretionary | 10.78% |
| 5 | Industrials | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2451
Alto Ingredients
ALTO
$326M
| $4.26M | ﹤0.01% |
862,981
-1,407
| -0.2% | -$7.09K |
|
2452
Ecovyst
ECVT
$1.1B
| $4.25M | ﹤0.01% |
364,405
+8,209
| +2% | +$112K |
|
|
CPRX
2453
DELISTED
Catalyst Pharmaceutical
CPRX
| $4.25M | ﹤0.01% |
801,244
+2,005
| +0.3% | +$11K |
|
|
ATRS
2454
DELISTED
Antares Pharma, Inc.
ATRS
| $4.23M | ﹤0.01% |
1,161,372
+53,498
| +5% | +$216K |
|
|
TRHC
2455
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $4.21M | ﹤0.01% |
160,505
+3,005
| +2% | +$111K |
|
2456
Recursion Pharmaceuticals
RXRX
$1.78B
| $4.21M | ﹤0.01% |
182,772
+17,891
| +11% | +$507K |
|
2457
Phillips Edison & Co
PECO
$5.2B
| $4.14M | ﹤0.01% |
+134,922
| New | +$3.96M |
|
|
GAN
2458
DELISTED
GAN Ltd
GAN
| $4.13M | ﹤0.01% |
278,045
+127,465
| +85% | +$2.04M |
|
|
CFB
2459
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
| $4.13M | ﹤0.01% |
317,680
-5,229
| -2% | -$69.2K |
|
2460
CS Disco
LAW
$297M
| $4.12M | ﹤0.01% |
+86,010
| New | +$4.35M |
|
2461
Byline Bancorp
BY
$1.78B
| $4.12M | ﹤0.01% |
167,526
-120
| -0.1% | -$2.87K |
|
2462
N-able
NABL
$695M
| $4.1M | ﹤0.01% |
+330,664
| New | +$4.53M |
|
|
TSC
2463
DELISTED
TriState Capital Holdings, Inc.
TSC
| $4.1M | ﹤0.01% |
193,934
-1,795
| -0.9% | -$36.3K |
|
2464
Marcus Corp
MCS
$929M
| $4.09M | ﹤0.01% |
234,621
-82,395
| -26% | -$1.34M |
|
|
DX
2465
Dynex Capital
DX
$3.23B
| $4.09M | ﹤0.01% |
236,749
+26,350
| +13% | +$466K |
|
2466
Merchants Bancorp
MBIN
$2.54B
| $4.06M | ﹤0.01% |
154,121
+6,855
| +5% | +$170K |
|
2467
New Oriental
EDU
$8.33B
| $4.05M | ﹤0.01% |
197,714
+4,212
| +2% | +$134K |
|
2468
Peapack-Gladstone Financial
PGC
$822M
| $4.05M | ﹤0.01% |
121,488
-3,190
| -3% | -$103K |
|
2469
NRC Health Common Stock
NRC
$471M
| $4.03M | ﹤0.01% |
95,519
+1,299
| +1% | +$65.4K |
|
2470
Liquidity Services
LQDT
$1.35B
| $4.03M | ﹤0.01% |
186,354
-630
| -0.3% | -$14.4K |
|
2471
Barrett Business Services
BBSI
$800M
| $4.02M | ﹤0.01% |
210,952
+1,044
| +0.5% | +$19.5K |
|
2472
Lifestance Health
LFST
$4.67B
| $3.99M | ﹤0.01% |
+275,072
| New | +$5.3M |
|
2473
Eos Energy Enterprises
EOSE
$1.51B
| $3.98M | ﹤0.01% |
283,652
+87,526
| +45% | +$1.3M |
|
|
THR
2474
DELISTED
Thermon Group Holdings
THR
| $3.96M | ﹤0.01% |
228,849
-1,367
| -0.6% | -$22.7K |
|
2475
Shattuck Labs
STTK
$735M
| $3.95M | ﹤0.01% |
193,817
+78,208
| +68% | +$1.67M |
|
Similar funds
Charles Schwab's Q3 2021 Portfolio in Review
As of Q3 2021, Charles Schwab held 3,610 positions worth $306B, up 1.6% from $301B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q3 2021 filing shows 202 new, 2,185 increased, 922 reduced and 109 closed positions. Its largest new stake was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M. The largest sale was Vanguard FTSE Emerging Markets ETF, an estimated $210M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q3 2021 buy was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M.
- Charles Schwab added most to Moderna in Q3 2021, an estimated $269M increase.
- Charles Schwab's biggest Q3 2021 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $210M.
- Charles Schwab fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $195M.
- Charles Schwab's ten largest holdings make up 17% of its $306B portfolio in Q3 2021.
- Charles Schwab opened 202 new positions and closed 109 in Q3 2021.
- Charles Schwab's portfolio value rose 1.6% quarter-over-quarter to $306B.
Based on Charles Schwab's 13F filing for Q3 2021, filed 16 Nov 2021.